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Abstract
Background:  Guillain-Barré Syndrome (GBS), the leading cause of acute flaccid paralysis
worldwide, is an autoimmune disorder involving the loss of the myelin sheaths encasing peripheral
nerve axons, leading to a loss of nerve signaling and typically ascending paralysis. A number of
infectious triggers have been identified, with Campylobacter being most common. Limited data are
available regarding GBS in U.S. service members at a high risk of exposure to numerous GBS-
associated infectious agents.
Findings: Medical encounter data were obtained from the Armed Forces Health Surveillance
Center (Silver Spring, MD). Active duty personnel with an incident GBS diagnosis were matched
by age, sex, and time with up to 4 controls. Demographic, antecedent infectious gastroenteritis
(IGE), and deployment covariates were used to explore GBS risk in this population.
The overall incidence was 2.28/100,000 persons (95% confidence interval: 2.03–2.54) with 19.1%
(60/314) receiving GBS-related medical care for more than one year. The majority of cases were
male, Caucasian and under 25 years of age. There was an increased risk of GBS three months
following a documented episode of IGE (Odds Ratio: 5.33; p = 0.03). We also found an association
with service in the Air Force and Navy (compared to Army personnel) with odds ratios of 1.39 (p
= 0.05) and 1.44 (p = 0.02), respectively.
Conclusion: GBS incidence in the U.S. military is slightly higher than the general population and is
associated with an antecedent IGE. Future studies are warranted to assess whether there are GBS-
associated infectious or environmental exposures inherent to military populations.
Background
Guillain-Barré Syndrome (GBS) is the leading cause of
acute flaccid paralysis with an estimated worldwide inci-
dence of 1.1–1.8/100,000 persons and has been associ-
ated with $1.7 billion in yearly costs in the United States
alone [1,2]. Cases range from mild to severe disease and
recovery depends on disease severity. Symptoms usually
take 6 to 18 months to fully resolve, although a small pro-
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portion may require prolonged hospitalization or care [3-
5].
The association between GBS and antecedent infection
has been well described, with Campylobacter jejuni,
Cytomegalovirus (CMV), and Epstein-Barr virus (EBV)
commonly identified and C. jejuni being by far the most
frequent [6-11]. Interestingly, C. jejuni-associated GBS
may be associated with a more severe clinical presentation
[12].
Campylobacter is a leading bacterial cause of IGE world-
wide [13]. A number of studies also document C. jejuni as
a leading cause of travelers' diarrhea (TD) in U.S. military
personnel, particularly in Southeast Asia [14-16]. Addi-
tionally, military personnel are exposed to numerous
deployment-related vaccinations [17], which have also
been linked to several autoimmune diseases including
GBS [18,19].
Little data on GBS epidemiology in military populations
are available. Using data from the Defense Medical Sur-
veillance System (DMSS), from 1998 to 2007, we identi-
fied incident cases of GBS in active duty military
personnel and, utilizing a match case-control study
design, evaluated the association between GBS and acute
gastrointestinal infection and deployment.
Methods
Data were obtained from the Armed Forces Health Sur-
veillance Center (AFHSC) which oversees the Defense
Medical Surveillance System (DMSS), a database contain-
ing all medical encounters at military treatment facilities
for all active duty US military from 1998 to the present
[20]. Medical information was linked to demographic and
deployment databases. Prior to provision of the final
dataset for analysis, study identification numbers were
assigned and identifiable information was removed.
Cases were active duty US military personnel with a GBS
diagnosis (ICD9-CM code 357.0) between 1999 and
2007. We required two separate GBS-associated medical
encounters within 1 year of initial diagnosis to increase
specificity. Controls (≥4 per case) were identified from the
same medical encounter dataset, and were matched on
age (within 1 year), sex, and time (within 1 year) of an
unrelated medical encounter.
Additional covariates evaluated included type of medical
visit (inpatient or outpatient), marital status, rank, service
type, education and race. An antecedent episode of IGE in
the 1 year prior to censure was evaluated as a risk factor for
GBS. Deployment to a region of high TD risk (including
Iraq, Afghanistan, Southwest Asia and the Persian Gulf) in
the year preceding censure was also evaluated as a surro-
gate for prior IGE.
For each case, all GBS-related medical encounters were
evaluated. Cases with a year or more of GBS-related
encounters were classified as "chronic". The incidence of
GBS (with exact 95% confidence intervals) was estimated
using the number of cases and the number of active duty
US military personnel (from the Defense Medical Epide-
miology Database). Poisson regression was used to assess
temporal changes in incidence. The association between
GBS, antecedent IGE, operational deployment and other
covariates were explored using univariate conditional
logistic regression methods. Odds ratios (OR) were calcu-
lated with Wald 95% confidence intervals. All data were
analyzed using SAS v. 9.1 (SAS Institute, Cary, NC) with
an alpha of 0.05.
Results
The majority of cases were male (n = 262; 83.4%),
between the ages of 20 and 24 (n = 101; 32.2%), Cauca-
sian (n = 210; 66.9%) and single (n = 153; 48.7%) (table
1). Cases and controls were mostly enlisted (83.4% and
85.1%, respectively). The majority of cases (n = 226;
72.0%) and controls (n = 908; 72.3%) had no more than
a high school education. Cases were more commonly
Navy personnel (n = 101; 32.2%) than other branches of
service while controls were more commonly in the Army
(n = 466; 37.1%). Controls had no outcomes associated
with enteric infections. The most common ICD-9 code for
controls was V70.5, a routine health exam, accounting for
10.9% of included controls. No other single ICD-9
accounted for more than 5% of the controls.
Overall, GBS incidence was 2.28 (95% C.I.: 2.03, 2.54)
per 100,000 person-years (table 2). The incidence
increased from 2.35 in 1999 to 2.94 in 2007 with a spike
of cases in 2004 (figure 1). Although no significant
changes in GBS incidence were observed over the period
of observation, general fluctuations were seen. Navy per-
sonnel had the highest incidence of GBS in 5 of 9 (figure
1). Additionally, non-white and non-black females had
the highest incidence in five out of nine years with no
observable trends. The youngest age category (< 20 years
of age) had an increasing GBS incidence from 1999 to
2005 and had the highest incidence during 4 of those
years. Persons ≥ 40 years of age had a similar increasing
trend from 2003 to 2007.
The censoring diagnosis for most cases (52.5%) occurred
in an outpatient setting although 225 (71.7%) had an
inpatient GBS-related medical encounter during the
course of their medical care. After initial case presentation,
common GBS-related follow-up medical encounters
included: physical therapy (n = 53; 16.9%), occupationalBMC Research Notes 2009, 2:171 http://www.biomedcentral.com/1756-0500/2/171
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therapy (n = 24; 7.6%), rehabilitation (n = 49; 15.6%)
and speech therapy (5; 1.6%).
The median number of GBS-related medical visits is
shown in table 2. Although there was a trend toward a
higher number of follow-up visits for males, younger
cases (those in the 20 year age group), and those of race
"other," these differences were not significant. A total of
19.1% of cases received GBS-related medical care beyond
1 year after initial presentation.
In the three months prior to censure, cases had a higher
odds of a documented antecedent IGE compared to
matched controls (OR: 5.33; 95% C.I.: 1.19, 23.82),
although no specific IGE etiology was found (Table 3). We
were unable to identify a significant association between
GBS and prior deployment to a region with high TD risk
in the year preceding censure. However, 11 cases (3.5%)
had their initial GBS encounter during a deployment to
one of those regions. Compared to their Army counter-
parts, Air Force (OR: 1.4; 95% C.I.: 1.0, 1.9) and Navy
(OR: 1.4; 95% CI: 1.1, 2.0) personnel had a higher odds
of GBS. Education also appeared to be associated with an
increased odds of GBS with a higher odds in those with
doctorate degrees compared to those with no greater than
a high school education (OR: 2.28; 95% CI: 1.00 to 5.23).
This association was not observed across other education
categories.
Discussion
We found a slightly higher incidence of GBS (2.3/
100,000) in an active duty U.S. military population com-
pared to the general population estimates of 1.1 to 1.8/
100,000 recently reported [2]. This may represent a true
GBS risk among U.S. military personnel due to an
increased risk of exposures to known infectious triggers,
unknown triggers (infectious or non-infectious), or an
artifact of the methodology utilized. McGrogan et al
reported that "retrospective database studies" found an
overall higher GBS incidence compared to prospective
studies or retrospective medical record reviews [2]. This
may reflect incomplete or incorrect medical coding in
database studies, inadequate case-finding procedures or
poorly defined estimates of at risk populations in other
study designs. In an effort to minimize coding errors, we
required a GBS diagnosis on at least two separate medical
encounters, eliminating 285 possible cases and effectively
halving our incidence estimate. Of these 285, a majority
(n = 207) had an ICD9-CM of 357.0 in the first diagnostic
position and 33 had their lone GBS-related medical
encounter at an inpatient facility. Thus, our methodology
may have also biased our incidence estimates downward.
We found a bimodal distribution of incidence with high-
est rates in those under 25 and over 40 years of age.
Table 1: Demographic characteristics of U.S. military service 
members diagnosed with Guillain-Barré Syndrome between 
1999 and 2007 and their matched controls
Cases Controls
N3 1 4 1 , 2 5 6
Age1 28.7 (9.3) 28.6 (9.0)
Sex2
Female 52 (16.6) 208 (16.6)
Male 262 (83. 4) 1048 (83.4)
Race2
Black 55 (17.5) 215 (17.1)
White 210 (66.9) 794 (63.2)
Other 49 (15.6) 247 (19. 7)
Marital status2,3
Married 148 (47.1) 555 (44.2)
Single 153 (48.7) 651 (51.8)
Other 9 (2.9) 47 (3.7)
Rank2
Enlisted 262 (83.4) 1069 (85.1)
Officer 47 (15.0) 177 (14.1)
Warrant Officer 5 (1.6) 10 (0.8)
Service type2
Army 93 (29.6) 466 (37.1)
Air Force 80 (25.5) 289 (23.0)
Marines 40 (12.7) 147 (11.7)
Navy 101 (32.2) 354 (28.2)
Education level2,4
High school (or equivalent) 226 (72.0) 908 (72.3)BMC Research Notes 2009, 2:171 http://www.biomedcentral.com/1756-0500/2/171
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Although the biological mechanisms are uncertain and
the epidemiologic data are inconsistent, others have
reported similar findings. One hypothesis is that the peak
in late adolescence and early adulthood is associated with
a secondary peak in C. jejuni incidence in that age group
(in developed world populations), whereas the peak in an
elderly population may be associated with failed immu-
nosuppression mechanisms [21]. Others have hypothe-
sized an age-specific differential risk of Campylobacter-
attributable GBS [10]. Further research is needed to fully
understand this effect.
Prior IGE was associated with an increased GBS risk.
Although we were unable to attribute this increased risk
with a specific organism, the known Campylobacter asso-
ciation is the most likely causative agent [11]. Unfortu-
nately, the utilization of ICD9-CM codes to identify
infectious exposures, specifically those of GI origin, is lim-
ited by the scarcity of microbiologic work-up completed
on reporting patients. This has been well-described and
continues to be a source of likely non-differential expo-
sure misclassification in these types of studies [22]. Future
research should consider a more extensive case history to
identify common triggers within the active duty popula-
tion.
We found a significant increased odds of GBS among Air
Force and Navy personnel (compared to Army), and
among those with a doctorate degree (compared to no
Some college 27 (8.6) 95 (7.6)
Bachelor's degree 27 (8.6) 132 (10.5)
Master's degree 14 (4.5) 65 (5.2)
Doctorate degree 9 (2.9) 16 (1.3)
1 Mean (standard deviation)
2 Number (percent)
3 4 cases (1.3%) and 3 controls (0.2%) missing data
4 11 cases (3.5%) and 40 controls (3.2%) missing data
Table 1: Demographic characteristics of U.S. military service 
members diagnosed with Guillain-Barré Syndrome between 
1999 and 2007 and their matched controls (Continued)
Table 2: Incidence of GBS and number of GBS-related medical encounters in U.S. military service members diagnosed between 1999 
and 2007 stratified by demographic covariates
Covariate Incidence1 Number of GBS-
related medical 
visits2
Number of GBS-
related medical visits 1 
month post-censure2
Number of GBS-
related medical visits 1 
year post-censure2
Number of cases receiving 
GBS-related medical care 
beyond 1 year post-
censure3
Female 2.59 (1.93, 3.39) 6 (3, 18) 4 (2, 8) 6 (3, 16.5) 13 (25%)
Male 2.22 (1.96, 2.51) 9 (4, 17) 4 (2, 9) 8 (3, 17) 47 (18%)
< 20 3.48 (2.47, 4.75) 12 (7, 21) 7 (5. 12) 12 (7, 21) 4 (10%)
20–24 2.23 (1.82, 2.71) 10 (4, 18) 4 (2, 10) 10 (4, 18) 15 (15%)
25–29 2.21 (1.70, 2.83) 6 (3, 17) 4 (2, 9) 6 (3, 16) 9 (14%)
30–34 1.61 (1.11, 2.26) 5 (2, 15) 3 (2, 7) 5 (2, 15) 7 (21%)
35–39 1.73 (1.19, 2.45) 8.5 (3.5, 13.5) 2 (2, 5.5) 7.5 (3, 12.5) 10 (31%)
>= 40 3.29 (2.41, 4.39) 6.5 (3, 22) 3 (1, 9) 5.5 (2, 20) 15 (33%)
Black 2.07 (1.56, 2.70) 8 (3, 17) 5 (2, 13) 8 (3, 17) 8 (14%)
White 2.22 (1.93, 2.54) 8 (4, 17) 4 (2, 9) 8 (3, 17) 45 (21%)
Other 2.98 (2.21, 3.92) 10 (3, 18) 4 (2, 10) 10 (3, 18) 7 (14%)
Total 2.28 (2.03, 2.54) 8.5 (3, 17) 4 (2, 9) 8 (3, 17) 60 (19.1%)
1 Incidence per 100,000 with 95% exact binomial confidence intervals
2 Presented as a median number of visits with interquartile ranges
3 Presented number of cases with percent of subgroupBMC Research Notes 2009, 2:171 http://www.biomedcentral.com/1756-0500/2/171
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more than a high school education). This may reflect a
subgroup that was older than the overall study population
(mean: 42.9; standard deviation: 9.5) and may dispropor-
tionately represent the ≥ 40 age group, known to have
higher GBS rates [21]. Due to age-matching, we were una-
ble to assess age as an independent risk-factor. The associ-
ation with branch of service has not been previously
described. Possible contributing factors could be differ-
ences in infectious exposures unique to these 2 branches
and further study on the exact etiology of infectious trig-
gers in this population is needed. Additionally, these find-
ings may be associated with differential healthcare
utilization in these subgroups. While there is open access
to care for all active duty personnel, there may be differen-
tial health-seeking behaviors.
GBS is known to cause chronic disability in a minor pro-
portion if cases [9,21]. In our study, approximately 20%
of cases had multiple medical visits 1 year post-diagnosis.
This may be influenced by the fact that active duty military
personnel have essentially unfettered access to free medi-
cal care. However, the proportion of "chronic" cases was
similar to that reported by Forsberg et al albeit in an older
Swedish population [23]. In evaluating the diagnostic
codes of follow-on GBS-related medical visits, the most
common were associated with physical therapy, rehabili-
tation, and speech therapy. These data underscore the fact
that while GBS sequelae may be rare, the morbidity in
terms of loss of function and disability need to be
explored and considered when evaluating the importance
of infectious disease prevention.
We did not evaluate the differential odds of exposure to
other infectious agents with known GBS associations (e.g.,
CMV, EBV), nor did we evaluate the association with ante-
cedent vaccination. We did, however, evaluate deploy-
ment to military operations in the Middle East and
Southwest Asia in the year preceding censure as a poten-
tial surrogate for military relevant exposures and found no
association with GBS. We were unable to assess peacetime
deployments, specifically those to Southeast Asia, an area
with high rates of Campylobacter [24-26]. This represents
a significant limitation in the utilization of deployment as
a surrogate for potentially relevant exposures.
As mentioned, utilizing a medical encounter database has
inherent limitations and introduces some biases. First,
data coding errors and misclassification are inherent and
Incidence of GBS cases stratified by branch of military service Figure 1
Incidence of GBS cases stratified by branch of military service.BMC Research Notes 2009, 2:171 http://www.biomedcentral.com/1756-0500/2/171
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such errors are the source of numerous peer-reviewed
publications [27,28]. Another factor we were unable to
assess was infectious exposures occurring during deploy-
ment. The DMSS only includes medical encounters at
U.S.-based medical treatment facilities. This represents a
decreased likelihood of capturing potentially important
exposures, including IGE, which occur during deploy-
ment limiting the generalizability of these findings. Case-
finding and/or seroepidemiologic studies may more accu-
rately identify prior exposures and outcomes and mini-
mize the biases inherent in utilizing medical encounter
data.
In summary, this preliminary study found IGE as a trigger
for GBS, however questions remain regarding the etiology
of such infections, and further study is needed to identify
other common and potentially preventable triggers in this
population. Regardless, we have described a potentially
important infectious sequelae which may not factor in to
decreased mission readiness in a deployed operational
setting, but may present a significant preventable burden
from an individual's and the military health and disability
system's perspective.
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